TRU-Vu Monitors, a leading supplier of customizable industrial-grade video monitors, has released a new 21.5” industrial-grade LCD monitor.
Paragonix Technologies, the leading provider of donor organ preservation and transport systems, jas launched LIVERguard Donor Liver Preservation System in both the US and Europe, along with the launch of its clinical global registry, GUARDIAN-LIVER (Global Utilization And Registry Database for Improved preservAtion of doNor LIVERs).
GE Healthcare has unveiled its Revolution Apex platform – an industry first computed tomography (CT) platform with built-in scalability for onsite CT detector upgrades from 40 mm to 80 mm or 160 mm detector coverage – all without replacing the gantry.
The results of Olympus’ ongoing joint research programme to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were announced at the Japan Society of Digital Pathology Study annual meeting. The diagnostic tool achieved 100% sensitivity and 50% or more specificity for all gastric biopsy pathology specimens analysed.
Philips has signed an agreement to acquire Vesper Medical, a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease. The transaction, which is subject to customary closing conditions, is […]
42 Technology (42T), FIND, the global alliance for diagnostics, and Rutgers University have worked together to develop an innovative stool sample processing kit that has played a central role in informing the World Health Organization’s (WHO) recent policy update to improve the diagnosis of tuberculosis (TB) in children.
Cline Scientific AB has received clearance from the Swedish Ethical Review Authority for the collection and testing of human cartilage tissue as part of the StemCART project.
Owen Mumford, a global leader in the design and manufacture of medical devices, has announced its emissions reduction targets through the Science Based Targets initiative (SBTi). The company has set a target to achieve net zero by 2045 (to mirror the UK NHS target) in alignment with the recommendations of the 2015 Paris Agreement.
As the world reflects on the urgent messages of the UN Climate Change Conference (COP26), hospital leaders are increasingly aware of their responsibility to advance the sustainability agenda. Research shows that if the world’s healthcare sector were a country, it would be the fifth-largest emitter of carbon emissions on the planet, according to the The […]
According to the first global estimates of impacts of the pandemic on mental health, cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic. International Hospital reports on the research published in The Lancet. [1]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
